How many studies have been conducted on Insulin Detemir?

BiohacksAI has indexed 300 PubMed studies on Insulin Detemir, including 63 randomized controlled trials (RCTs). 77% of studies involve human subjects.

What are the main research areas for Insulin Detemir?

The primary research domains for Insulin Detemir are 🧬 Hormones, 🔥 Metabolic, 😴 Sleep. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Insulin Detemir

A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.

300+ PubMed studies analyzed · 63 RCTs · Evidence Score: 61

Research Domains

Insulin Detemir has been studied across 11 research domains including 🧬 Hormones, 🔥 Metabolic, 😴 Sleep, ❤️ Cardiovascular, 🫁 Liver & Detox. The primary research focus is 🧬 Hormones with 100% of studies addressing this area.

Loading evidence profile...

This evidence profile for Insulin Detemir is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.